Suppr超能文献

青少年和青年女性使用长效可逆避孕措施和接受性传播感染/人类免疫缺陷病毒相关服务的情况。

Use of Long-Acting Reversible Contraception Among Adolescent and Young Adult Women and Receipt of Sexually Transmitted Infection/Human Immunodeficiency Virus-Related Services.

机构信息

Division of Adolescent and School Health, Centers for Disease Control and Prevention, Atlanta, Georgia; Department of Behavioral Sciences and Health Education, Emory University Rollins School of Public Health, Atlanta, Georgia.

Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

出版信息

J Adolesc Health. 2018 Apr;62(4):417-423. doi: 10.1016/j.jadohealth.2017.10.017. Epub 2018 Feb 8.

Abstract

PURPOSE

Long-acting reversible contraceptive (LARC) methods do not require annual clinic visits for continuation, potentially impacting receipt of recommended sexually transmitted infection (STI)/human immunodeficiency virus (HIV) services for young women. We assess service receipt among new and continuing LARC users versus moderately and less effective method users and non-contraceptors.

METHODS

Using 2011-2015 National Survey of Family Growth data from sexually active women aged 15-24 years (n = 2,018), we conducted logistic comparisons of chlamydia, any STI and HIV testing, and sexual risk assessment in the past year by current contraceptive type.

RESULTS

Less than half of respondents were tested for chlamydia (40.9%), any STI (47.3%), or HIV (25.9%); 66.5% had their sexual risk assessed. Differences in service receipt between new and continuing LARC users as compared with moderately effective method users were not detected in multivariable models, except that continuing LARC users were less likely to be tested for HIV (adjusted prevalence ratio [aPR] = .52, 95% confidence interval [CI] = .32-.85). New, but not continuing, LARC users were more likely than less effective method users (aPR = 1.35, 95% CI = 1.03-1.76) and non-contraceptors (aPR = 1.43, 95% CI = 1.11-1.85) to have their sexual risk assessed, although both groups were more likely than non-contraceptors to be tested for chlamydia (new: aPR = 1.52, 95% CI = 1.08-2.15; continuing: aPR = 1.69, 95% CI = 1.24-2.29).

CONCLUSIONS

We found little evidence that LARC use was associated with lower prevalence of STI testing. However, new, but not continuing, LARC users, as compared with those not using a method requiring a clinic visit, were more likely to have had their risk assessed, suggesting that initiating LARC may offer an opportunity to receive services that does not persist.

摘要

目的

长效可逆避孕方法(LARC)不需要每年进行临床随访以维持避孕效果,这可能会影响年轻女性接受推荐的性传播感染(STI)/人类免疫缺陷病毒(HIV)服务。我们评估了新使用者和继续使用者与使用中度有效和不太有效的方法以及未使用避孕措施者相比,在获得服务方面的情况。

方法

使用 2011-2015 年全国性活跃女性生育调查数据(n=2018 名年龄在 15-24 岁的女性),我们通过当前避孕方法类型进行逻辑比较,评估过去一年中衣原体、任何 STI 和 HIV 检测以及性风险评估的情况。

结果

不到一半的受访者接受了衣原体(40.9%)、任何 STI(47.3%)或 HIV(25.9%)检测;66.5%接受了性风险评估。在多变量模型中,新使用者和继续使用者与使用中度有效方法者之间在服务获得方面的差异并不明显,但继续使用者接受 HIV 检测的可能性较低(调整后流行率比 [aPR]=0.52,95%置信区间 [CI]=0.32-0.85)。与使用不太有效的方法者(aPR=1.35,95%CI=1.03-1.76)和未使用避孕措施者(aPR=1.43,95%CI=1.11-1.85)相比,新使用者(aPR=1.35,95%CI=1.03-1.76)更有可能接受性风险评估,尽管与未使用避孕措施者相比,这两组人群更有可能接受衣原体检测(新使用者:aPR=1.52,95%CI=1.08-2.15;继续使用者:aPR=1.69,95%CI=1.24-2.29)。

结论

我们发现几乎没有证据表明 LARC 使用率与较低的 STI 检测率相关。然而,与不使用需要临床随访的方法者相比,新使用者(但不包括继续使用者)更有可能接受风险评估,这表明开始使用 LARC 可能提供了一个不会持续存在的获得服务的机会。

相似文献

8
Dual method use among long-acting reversible contraceptive users.长效可逆避孕方法使用者中双重方法的使用情况。
Eur J Contracept Reprod Health Care. 2018 Apr;23(2):97-104. doi: 10.1080/13625187.2018.1445850. Epub 2018 Mar 27.

引用本文的文献

2
Investigating College Women's Contraceptive Choices and Sexuality.调查大学女生的避孕选择与性行为
Int J Sex Health. 2021 Apr 24;33(3):268-282. doi: 10.1080/19317611.2021.1908477. eCollection 2021.
6
Using Reproductive Health as a Strategy to Engage Youth in Preventive Care.利用生殖健康作为策略,让青年参与预防保健。
J Adolesc Health. 2021 Sep;69(3):523-526. doi: 10.1016/j.jadohealth.2021.02.010. Epub 2021 Apr 3.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验